EU Commission clears Superior Essex to buy Invex

(Reuters) - The European Commission said in its approval that "a number
of effective competitors, which have sufficient spare capacity,
would remain in the market and would continue to be able to
constrain the behaviour of the merged entity".




Superior Essex makes wire and cable used for communications
and magnet wire. It supplies copper and fibre optic
communications wire and cable products to telephone companies,
and its products are also used in transformers and generators.


Read more at Reuters.com Government Filings News

Zeltia shares soar after cancer drug approval

(Reuters) - MADRID, July 20 - Shares in Spanish drug company Zeltia soared on Friday after its cancer treatment Yondelis was recommended for approval in Europe, its first medicine to make its way to the market. Zeltia shares were 19.4 percent higher at 9.79 euros at 0800 GMT after the European Medicines Agency late on Thursday recommended Yondelis be approved by the European Commission, a process which usually takes a couple of months.



The company said Yondelis should be available to treat soft tissue sarcomas by the end of the year.


Read more at Reuters.com Government Filings News

UPDATE 1-EU panel backs Glaxo's cervical cancer vaccine

(Reuters) - Europe's largest drugmaker said an expert committee at the
European Medicines Agency had given a positive opinion on
Cervarix based on data from clinical trials involving the
vaccination of girls and women aged between 10 and 25.




Recommendations for marketing approval by the agency's
Committee for Medicinal Products for Human Use are normally
endorsed by the European Commission within a couple of months.


Read more at Reuters.com Government Filings News